

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine catabolic process (GO:0006554) | 5.71827872 |
| 2 | lysine metabolic process (GO:0006553) | 5.71827872 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 5.29170043 |
| 4 | fatty acid beta-oxidation (GO:0006635) | 5.26705893 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.10224859 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.10224859 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.97272033 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.97272033 |
| 9 | carnitine shuttle (GO:0006853) | 4.88123937 |
| 10 | fatty acid transmembrane transport (GO:1902001) | 4.85322013 |
| 11 | fatty acid oxidation (GO:0019395) | 4.77072158 |
| 12 | aspartate family amino acid catabolic process (GO:0009068) | 4.72882758 |
| 13 | 2-oxoglutarate metabolic process (GO:0006103) | 4.72044821 |
| 14 | lipid oxidation (GO:0034440) | 4.71165596 |
| 15 | fatty acid catabolic process (GO:0009062) | 4.66562289 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.61945517 |
| 17 | regulation of sequestering of triglyceride (GO:0010889) | 4.60423668 |
| 18 | short-chain fatty acid metabolic process (GO:0046459) | 4.60201049 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.57607750 |
| 20 | acetyl-CoA metabolic process (GO:0006084) | 4.57060412 |
| 21 | branched-chain amino acid catabolic process (GO:0009083) | 4.55336355 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.52684459 |
| 23 | behavioral response to nicotine (GO:0035095) | 4.42635619 |
| 24 | valine metabolic process (GO:0006573) | 4.37479639 |
| 25 | aromatic amino acid family catabolic process (GO:0009074) | 4.29202509 |
| 26 | branched-chain amino acid metabolic process (GO:0009081) | 4.28312133 |
| 27 | monocarboxylic acid catabolic process (GO:0072329) | 4.22256943 |
| 28 | cellular ketone body metabolic process (GO:0046950) | 4.21807355 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 4.18986622 |
| 30 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.17279901 |
| 31 | tricarboxylic acid metabolic process (GO:0072350) | 4.17121132 |
| 32 | succinate metabolic process (GO:0006105) | 4.11888531 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.11609429 |
| 34 | NADH metabolic process (GO:0006734) | 4.10037912 |
| 35 | biotin metabolic process (GO:0006768) | 4.04069343 |
| 36 | carnitine metabolic process (GO:0009437) | 4.00042275 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.98962112 |
| 38 | carnitine transmembrane transport (GO:1902603) | 3.96535022 |
| 39 | amino-acid betaine transport (GO:0015838) | 3.95330706 |
| 40 | carnitine transport (GO:0015879) | 3.95330706 |
| 41 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95116156 |
| 42 | response to pheromone (GO:0019236) | 3.93905372 |
| 43 | kynurenine metabolic process (GO:0070189) | 3.87648544 |
| 44 | regulation of fatty acid oxidation (GO:0046320) | 3.84381296 |
| 45 | cysteine metabolic process (GO:0006534) | 3.75064800 |
| 46 | respiratory chain complex IV assembly (GO:0008535) | 3.74342617 |
| 47 | positive regulation of fatty acid oxidation (GO:0046321) | 3.70139474 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 3.69819833 |
| 49 | ketone body metabolic process (GO:1902224) | 3.68716887 |
| 50 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.66595076 |
| 51 | ethanol oxidation (GO:0006069) | 3.64517731 |
| 52 | tryptophan catabolic process (GO:0006569) | 3.63298979 |
| 53 | indole-containing compound catabolic process (GO:0042436) | 3.63298979 |
| 54 | indolalkylamine catabolic process (GO:0046218) | 3.63298979 |
| 55 | bile acid biosynthetic process (GO:0006699) | 3.63019120 |
| 56 | fucose catabolic process (GO:0019317) | 3.61379533 |
| 57 | L-fucose metabolic process (GO:0042354) | 3.61379533 |
| 58 | L-fucose catabolic process (GO:0042355) | 3.61379533 |
| 59 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.60301238 |
| 60 | oxaloacetate metabolic process (GO:0006107) | 3.58487940 |
| 61 | organic acid catabolic process (GO:0016054) | 3.56825382 |
| 62 | carboxylic acid catabolic process (GO:0046395) | 3.56825382 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 3.52661617 |
| 64 | acyl-CoA biosynthetic process (GO:0071616) | 3.50570328 |
| 65 | thioester biosynthetic process (GO:0035384) | 3.50570328 |
| 66 | cytochrome complex assembly (GO:0017004) | 3.50207480 |
| 67 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.49716228 |
| 68 | tryptophan metabolic process (GO:0006568) | 3.47719194 |
| 69 | quaternary ammonium group transport (GO:0015697) | 3.44624703 |
| 70 | thioester metabolic process (GO:0035383) | 3.43812908 |
| 71 | acyl-CoA metabolic process (GO:0006637) | 3.43812908 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 3.43784375 |
| 73 | protein complex biogenesis (GO:0070271) | 3.43615440 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 3.43551759 |
| 75 | homocysteine metabolic process (GO:0050667) | 3.38774035 |
| 76 | coenzyme catabolic process (GO:0009109) | 3.35709479 |
| 77 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.33311613 |
| 78 | regulation of cofactor metabolic process (GO:0051193) | 3.32430776 |
| 79 | regulation of coenzyme metabolic process (GO:0051196) | 3.32430776 |
| 80 | phospholipid homeostasis (GO:0055091) | 3.31539999 |
| 81 | fatty acid homeostasis (GO:0055089) | 3.23267172 |
| 82 | acylglycerol homeostasis (GO:0055090) | 3.21206862 |
| 83 | triglyceride homeostasis (GO:0070328) | 3.21206862 |
| 84 | regulation of cholesterol metabolic process (GO:0090181) | 3.20907264 |
| 85 | sarcomere organization (GO:0045214) | 3.20394451 |
| 86 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.19515997 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.18846976 |
| 88 | glutamate metabolic process (GO:0006536) | 3.16225709 |
| 89 | drug transmembrane transport (GO:0006855) | 3.16112207 |
| 90 | signal peptide processing (GO:0006465) | 3.14329321 |
| 91 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.14204193 |
| 92 | bile acid metabolic process (GO:0008206) | 3.14198169 |
| 93 | plasma lipoprotein particle clearance (GO:0034381) | 3.13157029 |
| 94 | aromatic amino acid family metabolic process (GO:0009072) | 3.12693903 |
| 95 | regulation of hexokinase activity (GO:1903299) | 3.11016332 |
| 96 | regulation of glucokinase activity (GO:0033131) | 3.11016332 |
| 97 | serine family amino acid catabolic process (GO:0009071) | 3.10826318 |
| 98 | epithelial cilium movement (GO:0003351) | 3.10296522 |
| 99 | complement activation, alternative pathway (GO:0006957) | 3.08757709 |
| 100 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.08652819 |
| 101 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.08652819 |
| 102 | NADH dehydrogenase complex assembly (GO:0010257) | 3.08652819 |
| 103 | urea metabolic process (GO:0019627) | 3.08028331 |
| 104 | urea cycle (GO:0000050) | 3.08028331 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.06524375 |
| 106 | nonmotile primary cilium assembly (GO:0035058) | 3.05030220 |
| 107 | response to mercury ion (GO:0046689) | 3.02795476 |
| 108 | cellular modified amino acid catabolic process (GO:0042219) | 3.02605038 |
| 109 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.01396998 |
| 110 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.00835725 |
| 111 | small molecule catabolic process (GO:0044282) | 2.98106353 |
| 112 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.96758963 |
| 113 | protein carboxylation (GO:0018214) | 2.96758963 |
| 114 | tyrosine metabolic process (GO:0006570) | 2.96396337 |
| 115 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.95949139 |
| 116 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.94421414 |
| 117 | platelet dense granule organization (GO:0060155) | 2.94384700 |
| 118 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.93678501 |
| 119 | dicarboxylic acid catabolic process (GO:0043649) | 2.93647209 |
| 120 | cardiac myofibril assembly (GO:0055003) | 2.91969169 |
| 121 | nitrogen cycle metabolic process (GO:0071941) | 2.90328868 |
| 122 | negative regulation of telomere maintenance (GO:0032205) | 2.89074303 |
| 123 | triglyceride catabolic process (GO:0019433) | 2.86975296 |
| 124 | kidney morphogenesis (GO:0060993) | 2.86465338 |
| 125 | regulation of protein activation cascade (GO:2000257) | 2.85963475 |
| 126 | very long-chain fatty acid metabolic process (GO:0000038) | 2.84844220 |
| 127 | gamma-aminobutyric acid transport (GO:0015812) | 2.83747248 |
| 128 | creatine metabolic process (GO:0006600) | 2.83070899 |
| 129 | detection of light stimulus involved in visual perception (GO:0050908) | 2.82282340 |
| 130 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.82282340 |
| 131 | DNA deamination (GO:0045006) | 2.81596404 |
| 132 | axoneme assembly (GO:0035082) | 2.80979043 |
| 133 | regulation of cilium movement (GO:0003352) | 2.80738858 |
| 134 | amino acid salvage (GO:0043102) | 2.79777580 |
| 135 | L-methionine salvage (GO:0071267) | 2.79777580 |
| 136 | L-methionine biosynthetic process (GO:0071265) | 2.79777580 |
| 137 | photoreceptor cell maintenance (GO:0045494) | 2.73039314 |
| 138 | cellular biogenic amine catabolic process (GO:0042402) | 2.72553068 |
| 139 | amine catabolic process (GO:0009310) | 2.72553068 |
| 140 | cilium organization (GO:0044782) | 2.71937948 |
| 141 | cilium movement (GO:0003341) | 2.68618322 |
| 142 | indole-containing compound metabolic process (GO:0042430) | 2.66093113 |
| 143 | ubiquinone biosynthetic process (GO:0006744) | 2.65068814 |
| 144 | cilium assembly (GO:0042384) | 2.64957487 |
| 145 | mannosylation (GO:0097502) | 2.63331891 |
| 146 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.62885885 |
| 147 | DNA double-strand break processing (GO:0000729) | 2.62488861 |
| 148 | S-adenosylmethionine metabolic process (GO:0046500) | 2.61829972 |
| 149 | cilium morphogenesis (GO:0060271) | 2.61730638 |
| 150 | regulation of action potential (GO:0098900) | 2.59441523 |
| 151 | maturation of 5.8S rRNA (GO:0000460) | 2.58666473 |
| 152 | protein localization to cilium (GO:0061512) | 2.58579835 |
| 153 | reflex (GO:0060004) | 2.57802849 |
| 154 | methionine biosynthetic process (GO:0009086) | 2.57394093 |
| 155 | replication fork processing (GO:0031297) | 2.56975806 |
| 156 | protein-cofactor linkage (GO:0018065) | 2.55897943 |
| 157 | dopamine transport (GO:0015872) | 2.55055619 |
| 158 | intraciliary transport (GO:0042073) | 2.53817200 |
| 159 | ubiquinone metabolic process (GO:0006743) | 2.50506819 |
| 160 | piRNA metabolic process (GO:0034587) | 2.48930445 |
| 161 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.48642027 |
| 162 | retinal cone cell development (GO:0046549) | 2.48489739 |
| 163 | drug catabolic process (GO:0042737) | 2.47939784 |
| 164 | neural tube formation (GO:0001841) | 2.45850160 |
| 165 | oxidative demethylation (GO:0070989) | 2.45217967 |
| 166 | protein K6-linked ubiquitination (GO:0085020) | 2.44443746 |
| 167 | exogenous drug catabolic process (GO:0042738) | 2.44169793 |
| 168 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.41921386 |
| 169 | neuronal action potential (GO:0019228) | 2.41839400 |
| 170 | reciprocal meiotic recombination (GO:0007131) | 2.40500747 |
| 171 | reciprocal DNA recombination (GO:0035825) | 2.40500747 |
| 172 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.39973755 |
| 173 | benzene-containing compound metabolic process (GO:0042537) | 2.38799552 |
| 174 | recombinational repair (GO:0000725) | 2.38736801 |
| 175 | primary amino compound metabolic process (GO:1901160) | 2.37509070 |
| 176 | inositol phosphate catabolic process (GO:0071545) | 2.37357847 |
| 177 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.37348619 |
| 178 | synapsis (GO:0007129) | 2.37092342 |
| 179 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.36966446 |
| 180 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.36966446 |
| 181 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.36966446 |
| 182 | C4-dicarboxylate transport (GO:0015740) | 2.36516166 |
| 183 | photoreceptor cell development (GO:0042461) | 2.36411507 |
| 184 | double-strand break repair via homologous recombination (GO:0000724) | 2.36353084 |
| 185 | protein polyglutamylation (GO:0018095) | 2.35685516 |
| 186 | auditory receptor cell stereocilium organization (GO:0060088) | 2.34950698 |
| 187 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.33990639 |
| 188 | sulfation (GO:0051923) | 2.31848249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.53877982 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.06209489 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.00896518 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.30394239 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.91671718 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.10578071 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.04583480 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.92984710 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.62443840 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.41276807 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.30158322 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 3.27657438 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92943784 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.85629778 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.59347012 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.54729308 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.52277164 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.49295604 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.46162051 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.33556472 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.30900736 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29766498 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 2.24192690 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 2.19754430 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.18258967 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17945982 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11304887 |
| 28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.05922007 |
| 29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.05362338 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02637632 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 2.01528732 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95170724 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.85788785 |
| 34 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.83641953 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83366475 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.83218050 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.81085973 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77598333 |
| 39 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.77586418 |
| 40 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.77586418 |
| 41 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75092039 |
| 42 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.72253195 |
| 43 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.71964292 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69381172 |
| 45 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.64868097 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64272273 |
| 47 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.61699268 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57200101 |
| 49 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.55086574 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54695812 |
| 51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50713724 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.50556547 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.50556547 |
| 54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.49918483 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.49647556 |
| 56 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.49543545 |
| 57 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49433289 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47679947 |
| 59 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.45598747 |
| 60 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.44070384 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.43361368 |
| 62 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.42192116 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.41724630 |
| 64 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.39319369 |
| 65 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.39319369 |
| 66 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38119367 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.36811066 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.36406042 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35013957 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34808617 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33238037 |
| 72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32530460 |
| 73 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.31774057 |
| 74 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31603672 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31598036 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31300971 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30013156 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29382168 |
| 79 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29295036 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29240846 |
| 81 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29107948 |
| 82 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29089244 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29089244 |
| 84 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.28859678 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26900544 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26365420 |
| 87 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.25368614 |
| 88 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24596242 |
| 89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23575269 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23025085 |
| 91 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21297256 |
| 92 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21157860 |
| 93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.19939948 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18546501 |
| 95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18439116 |
| 96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18423417 |
| 97 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.16735331 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16383374 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16383374 |
| 100 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.15146325 |
| 101 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.14690657 |
| 102 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14125933 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13590862 |
| 104 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.12043691 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11297763 |
| 106 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11287738 |
| 107 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10573551 |
| 108 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09053771 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08570668 |
| 110 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08455129 |
| 111 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08029261 |
| 112 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07446386 |
| 113 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07004928 |
| 114 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06328986 |
| 115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06122385 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05720446 |
| 117 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05281426 |
| 118 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03746084 |
| 119 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03582465 |
| 120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01700382 |
| 121 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.01646280 |
| 122 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99215810 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99100841 |
| 124 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99033858 |
| 125 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98859511 |
| 126 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98859511 |
| 127 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98551944 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96921552 |
| 129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96897465 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95588061 |
| 131 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93432500 |
| 132 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93068772 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91479209 |
| 134 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87886390 |
| 135 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87712380 |
| 136 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.87289620 |
| 137 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86710607 |
| 138 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.86148641 |
| 139 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.84426352 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83823933 |
| 141 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83422148 |
| 142 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82278845 |
| 143 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81955007 |
| 144 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81663850 |
| 145 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81018196 |
| 146 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80801249 |
| 147 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79693526 |
| 148 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.78888066 |
| 149 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77852013 |
| 150 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77390991 |
| 151 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76837060 |
| 152 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74991295 |
| 153 | CBP_21632823_ChIP-Seq_H3396_Human | 0.73255238 |
| 154 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73207251 |
| 155 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.72728925 |
| 156 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.71839059 |
| 157 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69911847 |
| 158 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.69314208 |
| 159 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68540390 |
| 160 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.67684481 |
| 161 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66212921 |
| 162 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65776298 |
| 163 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65609398 |
| 164 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.65394914 |
| 165 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64166033 |
| 166 | AR_20517297_ChIP-Seq_VCAP_Human | 0.63561231 |
| 167 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.62484767 |
| 168 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61765485 |
| 169 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60416938 |
| 170 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.60286742 |
| 171 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.59943326 |
| 172 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.55622311 |
| 173 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.55469300 |
| 174 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55437198 |
| 175 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.54547154 |
| 176 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.54528728 |
| 177 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.53917309 |
| 178 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52793147 |
| 179 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52555030 |
| 180 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.52549845 |
| 181 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.52531710 |
| 182 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.52310156 |
| 183 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.52266888 |
| 184 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.51394372 |
| 185 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.51073641 |
| 186 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50170565 |
| 187 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.50043808 |
| 188 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.49555227 |
| 189 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.49316635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.03422934 |
| 2 | MP0005360_urolithiasis | 4.72233177 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 4.34490660 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.04869921 |
| 5 | MP0005365_abnormal_bile_salt | 3.91357088 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.25368786 |
| 7 | MP0003646_muscle_fatigue | 3.18603632 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.01771310 |
| 9 | MP0004130_abnormal_muscle_cell | 2.86843228 |
| 10 | MP0005670_abnormal_white_adipose | 2.74296132 |
| 11 | MP0004084_abnormal_cardiac_muscle | 2.71982986 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.65610656 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.61407393 |
| 14 | MP0005332_abnormal_amino_acid | 2.59517846 |
| 15 | MP0003195_calcinosis | 2.58797086 |
| 16 | MP0003252_abnormal_bile_duct | 2.56187231 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.49795295 |
| 18 | MP0005330_cardiomyopathy | 2.37406129 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.35914713 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 2.32223140 |
| 21 | MP0000751_myopathy | 2.29095816 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 2.23126277 |
| 23 | MP0006072_abnormal_retinal_apoptosis | 2.15210000 |
| 24 | MP0005666_abnormal_adipose_tissue | 2.10789342 |
| 25 | MP0000749_muscle_degeneration | 2.07555052 |
| 26 | MP0009840_abnormal_foam_cell | 2.07468217 |
| 27 | MP0003136_yellow_coat_color | 1.98071059 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.97729502 |
| 29 | MP0002102_abnormal_ear_morphology | 1.96989166 |
| 30 | MP0002638_abnormal_pupillary_reflex | 1.96886828 |
| 31 | MP0009046_muscle_twitch | 1.94196769 |
| 32 | MP0002938_white_spotting | 1.88313455 |
| 33 | MP0004142_abnormal_muscle_tone | 1.88075569 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.84035855 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.83800809 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.83206852 |
| 37 | MP0005253_abnormal_eye_physiology | 1.82560419 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.80891546 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.78459082 |
| 40 | MP0004043_abnormal_pH_regulation | 1.78087380 |
| 41 | MP0001485_abnormal_pinna_reflex | 1.77235274 |
| 42 | MP0002972_abnormal_cardiac_muscle | 1.74812336 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.73397850 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.73346250 |
| 45 | MP0001666_abnormal_nutrient_absorption | 1.70487101 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.69805180 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68016991 |
| 48 | MP0005083_abnormal_biliary_tract | 1.66827926 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.65584812 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.64882397 |
| 51 | MP0004087_abnormal_muscle_fiber | 1.61449357 |
| 52 | MP0002971_abnormal_brown_adipose | 1.60177372 |
| 53 | MP0003186_abnormal_redox_activity | 1.58201012 |
| 54 | MP0001984_abnormal_olfaction | 1.57236637 |
| 55 | MP0000609_abnormal_liver_physiology | 1.56210008 |
| 56 | MP0004885_abnormal_endolymph | 1.55640133 |
| 57 | MP0009745_abnormal_behavioral_response | 1.55410180 |
| 58 | MP0008872_abnormal_physiological_respon | 1.54012420 |
| 59 | MP0005620_abnormal_muscle_contractility | 1.53656871 |
| 60 | MP0003011_delayed_dark_adaptation | 1.51794327 |
| 61 | MP0000427_abnormal_hair_cycle | 1.51745318 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.50759731 |
| 63 | MP0001544_abnormal_cardiovascular_syste | 1.48112405 |
| 64 | MP0005385_cardiovascular_system_phenoty | 1.48112405 |
| 65 | MP0002272_abnormal_nervous_system | 1.46618675 |
| 66 | MP0002736_abnormal_nociception_after | 1.46179955 |
| 67 | MP0003787_abnormal_imprinting | 1.44650054 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.42656230 |
| 69 | MP0002269_muscular_atrophy | 1.42144279 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 1.41070862 |
| 71 | MP0003137_abnormal_impulse_conducting | 1.38937810 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 1.38703322 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 1.37862075 |
| 74 | MP0003718_maternal_effect | 1.37244514 |
| 75 | MP0005375_adipose_tissue_phenotype | 1.34827453 |
| 76 | MP0004133_heterotaxia | 1.34683532 |
| 77 | MP0004019_abnormal_vitamin_homeostasis | 1.34302163 |
| 78 | MP0005535_abnormal_body_temperature | 1.31588964 |
| 79 | MP0001486_abnormal_startle_reflex | 1.29723415 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 1.29201461 |
| 81 | MP0010630_abnormal_cardiac_muscle | 1.28022206 |
| 82 | MP0000747_muscle_weakness | 1.26579898 |
| 83 | MP0003690_abnormal_glial_cell | 1.25876053 |
| 84 | MP0001764_abnormal_homeostasis | 1.24032309 |
| 85 | MP0001501_abnormal_sleep_pattern | 1.23830994 |
| 86 | MP0006138_congestive_heart_failure | 1.23815548 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 1.22394828 |
| 88 | MP0004484_altered_response_of | 1.20581765 |
| 89 | MP0001529_abnormal_vocalization | 1.20320007 |
| 90 | MP0003880_abnormal_central_pattern | 1.20143618 |
| 91 | MP0008058_abnormal_DNA_repair | 1.19976879 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 1.19259948 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 1.17793494 |
| 94 | MP0002163_abnormal_gland_morphology | 1.17730617 |
| 95 | MP0002557_abnormal_social/conspecific_i | 1.14827713 |
| 96 | MP0002572_abnormal_emotion/affect_behav | 1.12512070 |
| 97 | MP0003122_maternal_imprinting | 1.09356330 |
| 98 | MP0003283_abnormal_digestive_organ | 1.09091217 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 1.07824445 |
| 100 | MP0005389_reproductive_system_phenotype | 1.07519889 |
| 101 | MP0002106_abnormal_muscle_physiology | 1.07389497 |
| 102 | MP0002064_seizures | 1.07263283 |
| 103 | MP0000750_abnormal_muscle_regeneration | 1.07075482 |
| 104 | MP0005386_behavior/neurological_phenoty | 1.05425298 |
| 105 | MP0004924_abnormal_behavior | 1.05425298 |
| 106 | MP0009780_abnormal_chondrocyte_physiolo | 1.05049349 |
| 107 | MP0005058_abnormal_lysosome_morphology | 1.04676124 |
| 108 | MP0002160_abnormal_reproductive_system | 1.04107631 |
| 109 | MP0004147_increased_porphyrin_level | 1.03784353 |
| 110 | MP0005334_abnormal_fat_pad | 1.03596580 |
| 111 | MP0005451_abnormal_body_composition | 1.02974754 |
| 112 | MP0002653_abnormal_ependyma_morphology | 1.01882208 |
| 113 | MP0004085_abnormal_heartbeat | 1.01242601 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.99890889 |
| 115 | MP0003950_abnormal_plasma_membrane | 0.99188021 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.98803473 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.98282470 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.97970876 |
| 119 | MP0005174_abnormal_tail_pigmentation | 0.97290986 |
| 120 | MP0003724_increased_susceptibility_to | 0.96063039 |
| 121 | MP0002254_reproductive_system_inflammat | 0.95760310 |
| 122 | MP0005266_abnormal_metabolism | 0.95657487 |
| 123 | MP0001919_abnormal_reproductive_system | 0.95398436 |
| 124 | MP0001661_extended_life_span | 0.95302239 |
| 125 | MP0003121_genomic_imprinting | 0.94091116 |
| 126 | MP0005410_abnormal_fertilization | 0.92350992 |
| 127 | MP0005075_abnormal_melanosome_morpholog | 0.91347317 |
| 128 | MP0002928_abnormal_bile_duct | 0.91166662 |
| 129 | MP0000013_abnormal_adipose_tissue | 0.90045578 |
| 130 | MP0000383_abnormal_hair_follicle | 0.89697518 |
| 131 | MP0005195_abnormal_posterior_eye | 0.89648205 |
| 132 | MP0010386_abnormal_urinary_bladder | 0.89146688 |
| 133 | MP0005165_increased_susceptibility_to | 0.89035036 |
| 134 | MP0005636_abnormal_mineral_homeostasis | 0.88383481 |
| 135 | MP0001756_abnormal_urination | 0.88048980 |
| 136 | MP0002067_abnormal_sensory_capabilities | 0.88017356 |
| 137 | MP0001970_abnormal_pain_threshold | 0.87054359 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.86907552 |
| 139 | MP0003868_abnormal_feces_composition | 0.85205633 |
| 140 | MP0000647_abnormal_sebaceous_gland | 0.84832368 |
| 141 | MP0002693_abnormal_pancreas_physiology | 0.83881291 |
| 142 | MP0003698_abnormal_male_reproductive | 0.83841617 |
| 143 | MP0001944_abnormal_pancreas_morphology | 0.83769195 |
| 144 | MP0005369_muscle_phenotype | 0.83480068 |
| 145 | MP0000003_abnormal_adipose_tissue | 0.82468521 |
| 146 | MP0002734_abnormal_mechanical_nocicepti | 0.81807571 |
| 147 | MP0002733_abnormal_thermal_nociception | 0.81152534 |
| 148 | MP0000343_altered_response_to | 0.80423318 |
| 149 | MP0001929_abnormal_gametogenesis | 0.79463306 |
| 150 | MP0001324_abnormal_eye_pigmentation | 0.78670448 |
| 151 | MP0002876_abnormal_thyroid_physiology | 0.78422870 |
| 152 | MP0002735_abnormal_chemical_nociception | 0.78159924 |
| 153 | MP0003828_pulmonary_edema | 0.77782335 |
| 154 | MP0002063_abnormal_learning/memory/cond | 0.77396382 |
| 155 | MP0008789_abnormal_olfactory_epithelium | 0.75872719 |
| 156 | MP0010368_abnormal_lymphatic_system | 0.74827046 |
| 157 | MP0005448_abnormal_energy_balance | 0.74514106 |
| 158 | MP0009115_abnormal_fat_cell | 0.74160682 |
| 159 | MP0005376_homeostasis/metabolism_phenot | 0.73713837 |
| 160 | MP0000604_amyloidosis | 0.73046671 |
| 161 | MP0009642_abnormal_blood_homeostasis | 0.73000128 |
| 162 | MP0000598_abnormal_liver_morphology | 0.72016042 |
| 163 | MP0009763_increased_sensitivity_to | 0.71540539 |
| 164 | MP0001765_abnormal_ion_homeostasis | 0.70395771 |
| 165 | MP0008438_abnormal_cutaneous_collagen | 0.67977190 |
| 166 | MP0004145_abnormal_muscle_electrophysio | 0.66702546 |
| 167 | MP0009697_abnormal_copulation | 0.66137639 |
| 168 | MP0004233_abnormal_muscle_weight | 0.65751742 |
| 169 | MP0003329_amyloid_beta_deposits | 0.64959999 |
| 170 | MP0009764_decreased_sensitivity_to | 0.63681581 |
| 171 | MP0008469_abnormal_protein_level | 0.62945825 |
| 172 | MP0002970_abnormal_white_adipose | 0.61530107 |
| 173 | MP0002909_abnormal_adrenal_gland | 0.59904288 |
| 174 | MP0002127_abnormal_cardiovascular_syste | 0.58956630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.11467309 |
| 2 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.55000719 |
| 3 | Myoglobinuria (HP:0002913) | 4.44696755 |
| 4 | Hyperglycinuria (HP:0003108) | 4.43563222 |
| 5 | Ketoacidosis (HP:0001993) | 4.40569446 |
| 6 | Ketosis (HP:0001946) | 4.32426278 |
| 7 | Pancreatic cysts (HP:0001737) | 4.26112651 |
| 8 | Hyperammonemia (HP:0001987) | 4.22745823 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.04593150 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.03168225 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.03168225 |
| 12 | Dicarboxylic aciduria (HP:0003215) | 4.00226937 |
| 13 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.00226937 |
| 14 | Pancreatic fibrosis (HP:0100732) | 3.98893930 |
| 15 | True hermaphroditism (HP:0010459) | 3.85278380 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.81484641 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 3.79707174 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.79707174 |
| 19 | Hepatic necrosis (HP:0002605) | 3.75748660 |
| 20 | Generalized aminoaciduria (HP:0002909) | 3.72286277 |
| 21 | Xanthomatosis (HP:0000991) | 3.68588307 |
| 22 | Sudden death (HP:0001699) | 3.63166744 |
| 23 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.56848574 |
| 24 | Exercise-induced myalgia (HP:0003738) | 3.53068920 |
| 25 | Cerebral edema (HP:0002181) | 3.42627873 |
| 26 | Nephronophthisis (HP:0000090) | 3.37956023 |
| 27 | Medial flaring of the eyebrow (HP:0010747) | 3.33477459 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.33003248 |
| 29 | Hyperglycinemia (HP:0002154) | 3.32166028 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 3.28263568 |
| 31 | Palpitations (HP:0001962) | 3.25380599 |
| 32 | Deep venous thrombosis (HP:0002625) | 3.25011970 |
| 33 | Calf muscle hypertrophy (HP:0008981) | 3.20361540 |
| 34 | Ventricular tachycardia (HP:0004756) | 3.19524309 |
| 35 | Congenital stationary night blindness (HP:0007642) | 3.13626998 |
| 36 | Exercise-induced muscle cramps (HP:0003710) | 3.10996125 |
| 37 | Acute encephalopathy (HP:0006846) | 3.09645721 |
| 38 | Increased muscle lipid content (HP:0009058) | 3.08735543 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 3.06341654 |
| 40 | Abnormality of the renal cortex (HP:0011035) | 3.02734217 |
| 41 | Abnormality of the renal medulla (HP:0100957) | 2.99054481 |
| 42 | Metabolic acidosis (HP:0001942) | 2.97610133 |
| 43 | Lethargy (HP:0001254) | 2.95728470 |
| 44 | Proximal tubulopathy (HP:0000114) | 2.94856472 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.92971354 |
| 46 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.91851519 |
| 47 | Hepatocellular necrosis (HP:0001404) | 2.88727314 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.87627460 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.87239149 |
| 50 | Type II lissencephaly (HP:0007260) | 2.85613724 |
| 51 | Gait imbalance (HP:0002141) | 2.85336443 |
| 52 | Hypolipoproteinemia (HP:0010981) | 2.83243050 |
| 53 | Right ventricular cardiomyopathy (HP:0011663) | 2.82027810 |
| 54 | Hypobetalipoproteinemia (HP:0003563) | 2.79377626 |
| 55 | Lipoatrophy (HP:0100578) | 2.75098504 |
| 56 | Congenital primary aphakia (HP:0007707) | 2.74295762 |
| 57 | Atrial fibrillation (HP:0005110) | 2.73554887 |
| 58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.73333974 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.73322214 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.73046609 |
| 61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.69494174 |
| 62 | Dilated cardiomyopathy (HP:0001644) | 2.67213413 |
| 63 | Cystic liver disease (HP:0006706) | 2.66470354 |
| 64 | Acute necrotizing encephalopathy (HP:0006965) | 2.64339069 |
| 65 | Attenuation of retinal blood vessels (HP:0007843) | 2.63457256 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.63252756 |
| 67 | Muscle fiber splitting (HP:0003555) | 2.61464728 |
| 68 | Large for gestational age (HP:0001520) | 2.60849885 |
| 69 | Hyporeflexia of lower limbs (HP:0002600) | 2.59134119 |
| 70 | Abnormality of serum amino acid levels (HP:0003112) | 2.58531149 |
| 71 | Nephrogenic diabetes insipidus (HP:0009806) | 2.58476922 |
| 72 | Hyperventilation (HP:0002883) | 2.58050134 |
| 73 | Vomiting (HP:0002013) | 2.57092309 |
| 74 | Complement deficiency (HP:0004431) | 2.56990330 |
| 75 | Nausea (HP:0002018) | 2.55529197 |
| 76 | Prolonged partial thromboplastin time (HP:0003645) | 2.55080721 |
| 77 | Pendular nystagmus (HP:0012043) | 2.54407953 |
| 78 | Abnormality of glycolysis (HP:0004366) | 2.53502254 |
| 79 | Increased serum pyruvate (HP:0003542) | 2.53502254 |
| 80 | Renal cortical cysts (HP:0000803) | 2.51067334 |
| 81 | Epidermoid cyst (HP:0200040) | 2.50010439 |
| 82 | Syncope (HP:0001279) | 2.48933885 |
| 83 | Asymmetric septal hypertrophy (HP:0001670) | 2.47682854 |
| 84 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.46691890 |
| 85 | Abnormality of alanine metabolism (HP:0010916) | 2.46691890 |
| 86 | Hyperalaninemia (HP:0003348) | 2.46691890 |
| 87 | Lactic acidosis (HP:0003128) | 2.46366868 |
| 88 | Gout (HP:0001997) | 2.45932991 |
| 89 | Sclerocornea (HP:0000647) | 2.45834525 |
| 90 | Methylmalonic acidemia (HP:0002912) | 2.45818777 |
| 91 | Primary atrial arrhythmia (HP:0001692) | 2.45769417 |
| 92 | Tubular atrophy (HP:0000092) | 2.45029932 |
| 93 | Chronic hepatic failure (HP:0100626) | 2.43626560 |
| 94 | Ragged-red muscle fibers (HP:0003200) | 2.41791626 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.40023804 |
| 96 | Increased intramyocellular lipid droplets (HP:0012240) | 2.39107130 |
| 97 | Abnormal drinking behavior (HP:0030082) | 2.38107978 |
| 98 | Polydipsia (HP:0001959) | 2.38107978 |
| 99 | Abnormality of urine glucose concentration (HP:0011016) | 2.38038338 |
| 100 | Glycosuria (HP:0003076) | 2.38038338 |
| 101 | Atrioventricular block (HP:0001678) | 2.34716911 |
| 102 | Supraventricular tachycardia (HP:0004755) | 2.33594284 |
| 103 | Increased CSF lactate (HP:0002490) | 2.31578489 |
| 104 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.31040435 |
| 105 | Gaze-evoked nystagmus (HP:0000640) | 2.29851718 |
| 106 | Supraventricular arrhythmia (HP:0005115) | 2.28776332 |
| 107 | Delayed CNS myelination (HP:0002188) | 2.28594747 |
| 108 | Progressive macrocephaly (HP:0004481) | 2.28457103 |
| 109 | Abnormality of the calf musculature (HP:0001430) | 2.28190360 |
| 110 | Pheochromocytoma (HP:0002666) | 2.27776267 |
| 111 | Conjunctival hamartoma (HP:0100780) | 2.24887393 |
| 112 | Furrowed tongue (HP:0000221) | 2.23272438 |
| 113 | Heart block (HP:0012722) | 2.23235202 |
| 114 | Bundle branch block (HP:0011710) | 2.23033827 |
| 115 | Genital tract atresia (HP:0001827) | 2.22011507 |
| 116 | Mitochondrial inheritance (HP:0001427) | 2.18721792 |
| 117 | Intestinal atresia (HP:0011100) | 2.18713330 |
| 118 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.18694825 |
| 119 | Vaginal atresia (HP:0000148) | 2.18570586 |
| 120 | Congenital hepatic fibrosis (HP:0002612) | 2.17993711 |
| 121 | Methylmalonic aciduria (HP:0012120) | 2.17722785 |
| 122 | Hyperbilirubinemia (HP:0002904) | 2.17398288 |
| 123 | Skin nodule (HP:0200036) | 2.16909286 |
| 124 | Abnormality of methionine metabolism (HP:0010901) | 2.16116657 |
| 125 | Congenital, generalized hypertrichosis (HP:0004540) | 2.15761142 |
| 126 | Hydroxyprolinuria (HP:0003080) | 2.14288500 |
| 127 | Abnormality of proline metabolism (HP:0010907) | 2.14288500 |
| 128 | Anencephaly (HP:0002323) | 2.13312188 |
| 129 | Hyperglycemia (HP:0003074) | 2.11841684 |
| 130 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11839847 |
| 131 | Poor coordination (HP:0002370) | 2.11467069 |
| 132 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.11290194 |
| 133 | Absent/shortened dynein arms (HP:0200106) | 2.11290194 |
| 134 | Prolonged QT interval (HP:0001657) | 2.10343183 |
| 135 | Abnormality of the common coagulation pathway (HP:0010990) | 2.09217713 |
| 136 | Abnormality of the labia minora (HP:0012880) | 2.08342601 |
| 137 | Ventricular arrhythmia (HP:0004308) | 2.08305412 |
| 138 | Neuroendocrine neoplasm (HP:0100634) | 2.06673968 |
| 139 | Cholelithiasis (HP:0001081) | 2.05707313 |
| 140 | Abnormal gallbladder morphology (HP:0012437) | 2.05375112 |
| 141 | Late onset (HP:0003584) | 2.05355240 |
| 142 | Hyperuricemia (HP:0002149) | 2.05105924 |
| 143 | Increased purine levels (HP:0004368) | 2.05105924 |
| 144 | Postaxial foot polydactyly (HP:0001830) | 2.03704437 |
| 145 | Increased corneal curvature (HP:0100692) | 2.03535695 |
| 146 | Keratoconus (HP:0000563) | 2.03535695 |
| 147 | Cerebellar dysplasia (HP:0007033) | 2.02499636 |
| 148 | Hypothermia (HP:0002045) | 2.01989659 |
| 149 | Abnormality of the pons (HP:0007361) | 2.00977995 |
| 150 | Inability to walk (HP:0002540) | 2.00778162 |
| 151 | Broad-based gait (HP:0002136) | 2.00470911 |
| 152 | Hemiparesis (HP:0001269) | 1.99754760 |
| 153 | Progressive inability to walk (HP:0002505) | 1.97228951 |
| 154 | Male pseudohermaphroditism (HP:0000037) | 1.96263644 |
| 155 | Decreased central vision (HP:0007663) | 1.95377440 |
| 156 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.92462664 |
| 157 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.92462664 |
| 158 | Lipid accumulation in hepatocytes (HP:0006561) | 1.92305939 |
| 159 | Lissencephaly (HP:0001339) | 1.90634381 |
| 160 | Polyuria (HP:0000103) | 1.88106365 |
| 161 | Concave nail (HP:0001598) | 1.87500926 |
| 162 | Fair hair (HP:0002286) | 1.86416156 |
| 163 | Bile duct proliferation (HP:0001408) | 1.86033050 |
| 164 | Abnormal biliary tract physiology (HP:0012439) | 1.86033050 |
| 165 | Decreased circulating renin level (HP:0003351) | 1.85765823 |
| 166 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.84582584 |
| 167 | Hypoplasia of the pons (HP:0012110) | 1.84237983 |
| 168 | Increased hepatocellular lipid droplets (HP:0006565) | 1.84136473 |
| 169 | Abnormality of vitamin B metabolism (HP:0004340) | 1.82748819 |
| 170 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.80840699 |
| 171 | Optic disc pallor (HP:0000543) | 1.78335884 |
| 172 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77563847 |
| 173 | Postaxial hand polydactyly (HP:0001162) | 1.75737640 |
| 174 | Dialeptic seizures (HP:0011146) | 1.75461329 |
| 175 | Abnormal ciliary motility (HP:0012262) | 1.75446577 |
| 176 | Optic nerve hypoplasia (HP:0000609) | 1.75307548 |
| 177 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.74753374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.54592758 |
| 2 | PDK4 | 3.82837209 |
| 3 | PDK3 | 3.82837209 |
| 4 | LMTK2 | 3.15555270 |
| 5 | TTN | 3.04759173 |
| 6 | OBSCN | 3.01483529 |
| 7 | TRIB3 | 2.72215390 |
| 8 | BMPR1B | 2.67942341 |
| 9 | PDK2 | 2.66441575 |
| 10 | MAP4K2 | 2.63919870 |
| 11 | MYLK | 2.59730232 |
| 12 | PKN2 | 2.52723234 |
| 13 | ADRBK2 | 2.51082163 |
| 14 | INSRR | 2.46572297 |
| 15 | PHKG2 | 2.42320301 |
| 16 | PHKG1 | 2.42320301 |
| 17 | GRK1 | 2.41132444 |
| 18 | ACVR1B | 2.28556734 |
| 19 | PINK1 | 2.25062104 |
| 20 | WNK4 | 2.19993448 |
| 21 | NUAK1 | 2.09802614 |
| 22 | ERN1 | 2.07748533 |
| 23 | SIK1 | 2.02432330 |
| 24 | TNIK | 1.91164935 |
| 25 | TIE1 | 1.77093858 |
| 26 | CASK | 1.75411507 |
| 27 | FLT3 | 1.75017350 |
| 28 | FGFR4 | 1.64539314 |
| 29 | NEK9 | 1.64347408 |
| 30 | MKNK2 | 1.57226379 |
| 31 | MAPK13 | 1.57139200 |
| 32 | STK39 | 1.54452485 |
| 33 | MAP3K4 | 1.53594330 |
| 34 | PIK3CA | 1.47333738 |
| 35 | NEK1 | 1.38126470 |
| 36 | MST4 | 1.35440494 |
| 37 | MUSK | 1.31881596 |
| 38 | PRKAA2 | 1.28639771 |
| 39 | TLK1 | 1.27492884 |
| 40 | CAMK1D | 1.20419351 |
| 41 | TRIM28 | 1.17014138 |
| 42 | PNCK | 1.14692318 |
| 43 | OXSR1 | 1.11715550 |
| 44 | MAP2K7 | 1.08464496 |
| 45 | PRKCG | 1.07895106 |
| 46 | FER | 1.05077724 |
| 47 | EPHB1 | 1.03069843 |
| 48 | MAPK12 | 1.02941792 |
| 49 | BRSK2 | 1.00361634 |
| 50 | STK16 | 0.99272901 |
| 51 | MAP3K7 | 0.99242046 |
| 52 | GRK7 | 0.98289256 |
| 53 | RIPK1 | 0.96923336 |
| 54 | PRKAA1 | 0.95203206 |
| 55 | TGFBR2 | 0.94669340 |
| 56 | MAP2K3 | 0.93189373 |
| 57 | DMPK | 0.92822822 |
| 58 | PRKCI | 0.91683180 |
| 59 | DAPK2 | 0.91577941 |
| 60 | STK24 | 0.91359317 |
| 61 | VRK1 | 0.91305966 |
| 62 | PRKD1 | 0.90824505 |
| 63 | PIK3CG | 0.90505789 |
| 64 | PLK2 | 0.89714776 |
| 65 | VRK2 | 0.89290889 |
| 66 | DYRK2 | 0.89247795 |
| 67 | CSNK1G1 | 0.89033573 |
| 68 | PLK3 | 0.88664289 |
| 69 | MST1R | 0.88025093 |
| 70 | JAK1 | 0.85102265 |
| 71 | MKNK1 | 0.84857723 |
| 72 | NTRK3 | 0.84379150 |
| 73 | KDR | 0.83620506 |
| 74 | FRK | 0.82974137 |
| 75 | EIF2AK3 | 0.82888447 |
| 76 | CAMK2D | 0.82315455 |
| 77 | PAK3 | 0.81649254 |
| 78 | PDPK1 | 0.79969916 |
| 79 | ADRBK1 | 0.79636835 |
| 80 | TAOK3 | 0.78842408 |
| 81 | SGK494 | 0.78716075 |
| 82 | SGK223 | 0.78716075 |
| 83 | MARK1 | 0.75593643 |
| 84 | CSNK1G2 | 0.75370771 |
| 85 | SGK3 | 0.75184010 |
| 86 | STK38L | 0.73511737 |
| 87 | WNK3 | 0.73189466 |
| 88 | NME1 | 0.73078056 |
| 89 | TGFBR1 | 0.72962449 |
| 90 | STK3 | 0.72237960 |
| 91 | MAPK11 | 0.72047958 |
| 92 | ERBB3 | 0.71591116 |
| 93 | WEE1 | 0.69928183 |
| 94 | PRKACG | 0.68953459 |
| 95 | CSNK1G3 | 0.68759111 |
| 96 | LATS1 | 0.68415340 |
| 97 | JAK2 | 0.67170101 |
| 98 | NLK | 0.66995896 |
| 99 | PDK1 | 0.66309668 |
| 100 | AKT3 | 0.63658815 |
| 101 | CSNK1A1L | 0.60706812 |
| 102 | SGK2 | 0.60036118 |
| 103 | PRKCH | 0.59969035 |
| 104 | TXK | 0.59901428 |
| 105 | CAMK1G | 0.59761645 |
| 106 | PKN1 | 0.59462846 |
| 107 | CAMK2G | 0.59373965 |
| 108 | PLK4 | 0.58069751 |
| 109 | MET | 0.57926274 |
| 110 | MAP3K3 | 0.57245216 |
| 111 | PLK1 | 0.57037489 |
| 112 | TAF1 | 0.56598078 |
| 113 | FGFR2 | 0.56456929 |
| 114 | WNK1 | 0.56033931 |
| 115 | CSNK1A1 | 0.52821280 |
| 116 | MAP2K6 | 0.52634891 |
| 117 | ROCK1 | 0.52556370 |
| 118 | EPHA4 | 0.52239305 |
| 119 | TYK2 | 0.52187346 |
| 120 | TSSK6 | 0.51742751 |
| 121 | MAP2K4 | 0.51008644 |
| 122 | ABL2 | 0.50871306 |
| 123 | ERBB4 | 0.50061834 |
| 124 | PRKG2 | 0.49525472 |
| 125 | BCR | 0.49124664 |
| 126 | MAP3K5 | 0.47532242 |
| 127 | CAMK4 | 0.47321515 |
| 128 | EPHA3 | 0.47018770 |
| 129 | PDGFRA | 0.46490226 |
| 130 | PTK6 | 0.46310009 |
| 131 | PRKCQ | 0.44659444 |
| 132 | ZAK | 0.44529274 |
| 133 | STK4 | 0.44006110 |
| 134 | PRKCE | 0.43514268 |
| 135 | STK11 | 0.42226936 |
| 136 | PTK2B | 0.42216799 |
| 137 | PRKACA | 0.41474845 |
| 138 | TRPM7 | 0.40416159 |
| 139 | IRAK3 | 0.40237789 |
| 140 | CAMKK2 | 0.39265269 |
| 141 | MAPKAPK5 | 0.39258428 |
| 142 | PRKCZ | 0.39020299 |
| 143 | TBK1 | 0.38968947 |
| 144 | GSK3A | 0.37290960 |
| 145 | RPS6KA5 | 0.36490437 |
| 146 | NEK2 | 0.36383320 |
| 147 | ILK | 0.36264125 |
| 148 | PRKACB | 0.36263237 |
| 149 | PRKG1 | 0.35983210 |
| 150 | CSNK1D | 0.35857103 |
| 151 | PRKCA | 0.35230255 |
| 152 | PASK | 0.34852499 |
| 153 | CAMK2A | 0.33109446 |
| 154 | BUB1 | 0.33070100 |
| 155 | MAPK7 | 0.32759399 |
| 156 | TTK | 0.32704985 |
| 157 | RET | 0.32637276 |
| 158 | ATM | 0.32493643 |
| 159 | MAPK15 | 0.32016198 |
| 160 | MAPK4 | 0.31948693 |
| 161 | MARK3 | 0.31556089 |
| 162 | CHEK2 | 0.31160109 |
| 163 | IGF1R | 0.31064907 |
| 164 | MAP2K1 | 0.30149438 |
| 165 | MAPKAPK3 | 0.29763422 |
| 166 | CAMK1 | 0.28535879 |
| 167 | ITK | 0.27173885 |
| 168 | DAPK3 | 0.25404569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.77182600 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.65971698 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.54765030 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.40802958 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.13476959 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.92700649 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.82319705 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78888226 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.75444798 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.59070547 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.55907638 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.40895667 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.31614409 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.26389848 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.24253296 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.24150173 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.23022496 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15281629 |
| 19 | Protein export_Homo sapiens_hsa03060 | 2.11543804 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 2.10805325 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 2.10444107 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 2.05092358 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.04221650 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.98277421 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83643954 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70092160 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.67926103 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.66939677 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.55562948 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.50525344 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.49498864 |
| 32 | Nicotine addiction_Homo sapiens_hsa05033 | 1.47473919 |
| 33 | RNA degradation_Homo sapiens_hsa03018 | 1.45957275 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44593404 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43900761 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.40463043 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.38035888 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.33489409 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31684661 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31089889 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30682308 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29625538 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25380347 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25270292 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25225590 |
| 46 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23930587 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.23714492 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23385344 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.21315261 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18101555 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15202166 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 1.13619258 |
| 53 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13283526 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12161959 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.07101167 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 1.06416295 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06401921 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06265528 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 1.04819726 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03602357 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03181284 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 1.01405753 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00304364 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.98867858 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98044935 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95308097 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94478361 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94321614 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92205560 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91118435 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89499954 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88764501 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.88137262 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86348054 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.85546069 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82623160 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80929376 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.80862327 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80786564 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.80521598 |
| 81 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.80029844 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79203628 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78271842 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77614053 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77076022 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.75227998 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.73744257 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71780879 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71216230 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68599380 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66714236 |
| 92 | Proteasome_Homo sapiens_hsa03050 | 0.65878986 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64760179 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61413854 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60593910 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60521078 |
| 97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59369184 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58459109 |
| 99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58046193 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.57927224 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57796048 |
| 102 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57567301 |
| 103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57269026 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57129664 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56987237 |
| 106 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56842142 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56482899 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55187286 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.54944389 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.51022924 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50710049 |
| 112 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48157480 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46859101 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46353570 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44064354 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42790021 |
| 117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41738287 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.40666937 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40099776 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37736926 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33150172 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24478333 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21699005 |
| 124 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20989492 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19617529 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.18400839 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06155923 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.02946806 |
| 129 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.01534551 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.00410280 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | -0.0622753 |
| 132 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0593614 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0541328 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0541127 |
| 135 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0446430 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0371940 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0362790 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0136207 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0008892 |

